IVIS imaging showed in vivo localization of PS targeting antibodies and the Gla-EGF fusion protein to the tumors at 24 (Fig.1.C.) and 48 hours (Fig.1.D.) after intraperitoneal injection, while Isotype antibody showed minimal tumor localization. Here, EGF is linked to neoplasm.